PERISCOPE

PERtussIS COrrelates of Protection Europe

Programme
Horizon 2020 & sub-programmes
Duration
78 months (March 2016 – August 2022)
Project funding
≈ €28 million
Project partners
21

What the project is about

PERISCOPE aims to accelerate the development of improved vaccines against Bordetella pertussis (whooping cough) and/or vaccination strategies that will be used to control B. pertussis in humans. PERISCOPE will develop novel functional antibody and cellular assays and employs cutting-edge methods to characterise innate immune responses and cell-mediated systemic and mucosal immunity.

Coordinator

Dimitri Diavatopoulos

Radboud University Medical Center

Explore THE COURT

Discover THE COURT, the EURICE environment where projects, expertise and partners connect across six innovation ecosystems.

Enter THE COURT